2004

UPDATE ON THE POLITICAL SCANDAL AT AIDS ACTION: Plus, the AIDS organizational crisis and diversification
Doug Ireland - December 28, 2004
There are serious new developments that underscore the AIDS community s organizational crisis. At AIDS Action, the national voice for AIDS service organizations and the largest AIDS lobby in Washington, the condoheads and AIDScrats who run it are quaking in their boots as they await the release of a soon-to-be-publishe


AIDS ACTION JUMPS INTO BED WITH BUSH AND THE AIDS-PHOBIC REPUBLICANS
Doug Ireland - December 24, 2004
It s mind-boggling: Marsha Martin, the executive director of AIDS Action--the AIDS community s largest, most visible, and wealthiest Washington lobby, with a multi-million dollar budget--has jumped into bed with the Bush-Rove Republicans with both feet. In a perfectly scandalous act of betrayal of the AIDS community, M


Statement by MU-JHU Research Collaboration Investigators
Makerere University, Johns Hopkins University Research Collaboration Investigators - December 22, 2004
Press reports on HIVNET 012, a clinical trial to determine the efficacy of oral nevirapine in comparison to oral AZT for the prevention of Mother To Child HIV-1 Transmission in pregnant HIV infected women and their Neonates in Uganda . An Associated Press Release and subsequent report printed


Making a list and checking it twice
AEGiS News - December 20, 2004
With Christmas drawing near, I m sure we are all checking our Christmas lists to make sure we have not forgotten anyone. Let s see... Mom, Dad, Grandma and Grandpa - check! Siblings, aunts and uncles - check! Partners, children...and the boss, can t forget the boss - check! Lets see, who might we have forgotten......?


Myanmar: Update on HIV/AIDS Policy
International Crisis Group - December 16, 2004
Yangon/Brussels, 16 December 2004: To combat its growing HIV/AIDS epidemic, Myanmar must urgently boost local staff capabilities and make more effective use of international aid. Myanmar: Update on HIV/AIDS Policy, the latest report from the International Crisis Group, describes the country s rate of HIV infection, one


PROJECT INFORM STATEMENT REGARDING THE USE OF SINGLE-DOSE NEVIRAPINE TO PREVENT MOTHER-TO-CHILD TRANSMISSION OF HIV
Project Inform - December 15, 2004
Martin Delaney, 415-558-8669, ext. 222
Articles from the Associated Press (AP) and other media sources appear to raise serious questions about the use of single-dose nevirapine to prevent mother-to-child transmission of HIV in resource poor countries. Although there is no new information about the safety and effectiveness of the use of this prevention strat


President Bush's $20 Million ADAP Initiative
NASTAD - December 15, 2004
What is the President s $20 million ADAP Initiative? On June 23, 2004, President Bush announced immediate availability of an additional $20 million in drug therapies for ten states with AIDS Drug Assistance Program (ADAP) waiting lists as of June 21, 2004. The ten states eligible to participate in this program are: Ala


New Survey of State AIDS Drug Assistance Programs (ADAPs) Shows Waiting Lists for Medications Persist
NASTAD Press Release - December 15, 2004
For further information, contact: Murray Penner, (202) 434-8090 Washington, DC - The National Alliance of State and Territorial AIDS Directors (NASTAD) has released its latest ADAP Watch, a listing of AIDS Drug Assistance Programs (ADAPs) that have implemented or anticipate implementing cost containment strategies to m


Boehringer Ingelheim provides key background on Viramune
Boehringer Ingelheim - December 15, 2004
In light of recent interest in the use of Viramune ® (nevirapine), Boehringer Ingelheim (BI) provides the following background information on the drug and key events that have been revisited by the media. Viramune has played a vital role in the fight against HIV/AIDS since its U.


Elizabeth Glaser Pediatric AIDS Foundation on Issue of Prevention of Mother-to-Child Transmission of HIV/AIDS and Single-Dose Nevirapine
Elizabeth Glaser AIDS Foundation - December 14, 2004
In response to an Associated Press (AP) article that revisits past questions about the drug nevirapine (NVP), the Elizabeth Glaser Pediatric AIDS Foundation is issuing this statement to clarify the scientific facts, based on the full body of evidence, regarding the use of this drug to prevent mother-to-child transmissi


THE FEMINIZATION OF AIDS
AEGiS News Service - November 30, 2004
Elizabeth Canepa
As we approach the 16th anniversary of the first World AIDS Day, this modern day Weapon of Mass Destruction is still taking its toll on the men, women and children of the world. This year the focus is on recognizing the impact this Disease has had on Women and young girls. Women and girls now account for nearly 50% of


THE TRAGEDY OF TODAY'S GAYS - An address to the gay community
A speech made at Cooper Union, New York - Sunday, November 7, 2004
Larry Kramer
(A speech made at Cooper Union, New York on Sunday, November 7, 2004, presented by HIV Forum in conjunction with NYU s Office of LGBT Student Services, Broadway Cares/Equity Fights Aids, Callen-Lorde, and the Gill Foundation.) I think this has been the most difficult speech I have ever had to write and to deliver. It i


Guidelines for the Prioritization of People on State ADAP Waiting Lists: An Interim Report to the Health Resources and Services Administration from the AIDS Drug Assistance Protocol Fund
AIDS Drug Assistance Protocol Fund - Report Date: October 26, 2004
Gordon Nary, Executive Director, AIDS Drug Assistance Protocol Fund
To let oneself be bound by a duty from the moment you see it approaching is part of the integrity that alone justifies responsibility. - Dag Hammarskjöld The AIDS Drug Assistance Protocol Fund commends the Health Resources and Services Administration (HRSA) for their interest in addressing the ethical challenges in th


Basketball Greats Yao Ming And Magic Johnson Break New Ground On HIV/AIDS Awareness In China
Chinese AIDS Initiative(CAI) - October 13, 2004
Adrien Fraise (CAI): 212-584-5008; Kathy Behrens (NBA): 212-407-8127
TV Ad Campaign with Chinese and U.S. Basketball Heroes is First of its Kind in China, Where HIV/AIDS is Spreading Rapidly NEW YORK - The Chinese AIDS Initiative (CAI), an alliance of Chinese and international partners dedicated to helping China accelerate its response to HIV/AIDS, and the National Basketball Associatio


14 Years of Service
AEGiS News Service - October 10, 2004
Elizabeth Canepa
On this the 14th anniversary of the beginning of AEGiS, we are reaching out to the Humanitarian within you. You may live in any part of the world and read our pleas for donations and wonder, why should I make a donation to AEGiS? Do I make a difference? Yes! You make a difference! When you contribute, you become an int


Experimental Aids Drug Blocked By Federal Panel, Poz Magazine Reports
POZ Magazine - September 21, 2004
Contact: Walter Armstrong, 212-242-2163 x203
PLUS: Sex, Lies and HIV--What happens when one positive man fesses up New York, September 21, 2004--The federal government has banned a 40-year-old generic chemotherapy drug for the treatment of HIV, even though some doctors believe it could be a lifesaver, an investigative story in the October issue of POZ reports.


PRESS RELEASE: AIDS Activists Outraged by Abbott Settlement with AIDS Healthcare Foundation
AIDS Treatment Activists Coalition (ATAC) - July 16, 2004
(NEW YORK, July 16) The news of a settlement reached between Abbott Laboratories and California-based AIDS Healthcare Foundation (AHF) in two lawsuits drew fire from the AIDS Treatment Activists Coalition (ATAC). The lawsuits were filed by AHF in response to a 400% price increase last December by Abbott for its drug


Moving Mountains
MotherJones.com - July 13, 2004
Peter Meredith**
In her new book, journalist and activist Anne-Christine d Adesky argues that access to AIDS medicine is a fundamental human rights issue. Anne-Christine d Adesky has been reporting from the front lines of the global AIDS epidemic since before it became a major story. A foreign correspondent stationed in


AIDS and algae: Public health researcher promotes HIV therapy with seaweed
USC Times* - July 2004
Chris Horn
Jane Teas, a researcher in the Arnold School of Public Health, has just returned from this summer s International Seaweed Symposium in Norway and the U.N. AIDS conference in Bangkok, Thailand . If you re wondering what the connection is between seaweed and AIDS, Teas can explain. She recently conducted a pilot study in


Leadership Program: XV International AIDS Conference 2004
List Serve Consultant, XV International AIDS Conference 2004
Get involved, use this opportunity to address a world leader and send us your questions. With Meet the Leaders , the new, interactive sessions from the Leadership Program at the International AIDS Conference in Bangkok, you can. 2004 is shaping up to be a year of unprecedented opportunities to fight HIV/AIDS and also a


What's It All About, Alfie?: Bill Arnold offers his perspectives on the $20 million ADAP emergency funding announcement.
ADAP: Interview Date: June 27, 2004
Subject: William E. Arnold; Interviewer: Gordon Nary
ADAP Fund: Many in the US AIDS community were taken by surprise by the June 23 White House Announcement that $20 million in HIV drugs will be distributed to states with ADAP waiting lists. Apparently the advocacy efforts by


Virtual AIDS Walk OC
AEGiS News - May 27, 2004
AEGiS is but one of the proud recipient agencies of the 18th Annual AIDS Walk Orange County, hosted by AIDS Services Foundation. Did you know that $212 billion dollars has been raised for this cause in the USA by events such as this? Nearly 10,000 of your closest friends and family will gather at UC Irvine on Sunday, J


The AEGiS Report
AEGiS News Service - May 4, 2004
Our ongoing effort to provide HIV/AIDS conference abstracts has lead to the completion of another International AIDS Society Conference being added to the AEGiS database. Our content assistant, April, has posted and made available to view on AEGiS, the 1st International AIDS Society Conference on HIV Pathogenesis and T


Botswana Communications Breakthrough Brings ARV Treatment Education to the Masses
Government of Botswana Ministry of Health - April 28, 2004
The launch of an animated patient education video marks the latest step in the Masa programme to mobilise communities on HIV/AIDS and ARV therapy in Botswana . Community mobilisation has been the cornerstone of Masas Information Education Communication (IEC) campaign and aims to not only inform and educate the communit


ARV access issues (6): COMPULSORY LICENSING: TRIPS Agreement Article 31, Doha Declaration on the TRIPS Agreement and Public Health, and Decision on Implementation of paragraph 6 of the Doha Declaration
JVnet Forum posting** - April 23, 2004
Trang and Ngoc
One of the important ways for developing and less developed countries to overcome the patent barriers to pharmaceuticals is compulsory licensing. What is compulsory licensing and what should people interested in ARV medicines know about compulsory licencing? As mentioned in earlier messages, it is common that patents a


ARV access issues (5): Efavirenz, a challenge for first-line ARV treatment in resource-limited settings
JVnet Forum posting** - April 22, 2004
Trang and Ngoc
WHO recommends that in resource-limited settings, the public health approach to treatment should use first-line regimens that combine three drugs as follows: ( d4T or AZT ) + 3TC + (NVP or


ARV ACCESS ISSUES (4): WTO's TRIPS Agreement and VN-US bilateral trade agreement
JVnet Forum posting** - April 21, 2004
Ngoc and Trang
These are two important documents related to patent protection in Viet Nam, thus also related to access to ARVs and other medicines. The TRIPS Agreement of WTO Viet Nam is currently negotiating for joining the World Trade Organization (WTO). This is a very important step for Viet Nam, as it will help the country integr


ARV ACCESS ISSUES (3): Do You Want To Know More About Patent Protection Related To ARV Medicines?
JVnet Forum posting** - April 20, 2004
Ngoc and Trang
The first posting in this series mentioned patent protection as a barrier to access to cheap generic drugs. The second posting mentioned the delay of patent protection of pharmaceuticals in India . Some JVNET readers may be wondering how patent protection in Viet Nam relates to ARV medicines. A WHO expert explained


Contaminated polio vaccine theory NOT refuted
Edward Hooper - April 20th, 2004
[Edward Hooper s response to the latest brief communication in Nature by Michael Worobey, Beatrice Hahn and colleagues, entitled Contaminated Polio Vaccine Theory Refuted . Nature; 2004; 428; 820.] Background. The first thing to notice about this one-page paper by Worobey et al. is the media blitz that has preceded it.


ARV ACCESS ISSUES (2): Why Is It That India Can Produce Cheap Generic ARV?
JVnet Forum posting** - April 19, 2004
Ngoc and Trang
The previous message mentioned cheap generics from India , and then talked about patent barriers to the production and importation in different countries. Did this question come to your mind, why is it that India can produce cheap generics for its people and for export to other countries, while many other countries can


ARV ACCESS ISSUES (1)
JVnet Forum posting** - April 16, 2004
Ngoc and Trang
Recently, JVNET posted the very good news that the Clinton Foundation succeeded in negotiating for reduction of ARV prices. VTV1 also carried this news in an upbeat tone. In my office, we were all very excited. There are clear potentials for affordable ARVs... that is, if some obstacles are overcome. As a matter of fac


AEGiS Update
AEGiS News - April 9, 2004
Elizabeth Canepa
New feature at AEGiS! We are pleased to announce the addition of HIV/AIDS-related news from the Voice of America (VOA). A small number of files are now available from 2002 and 2004. Look for additional files over the next few weeks. Voice of America news articles are available in both Real Audio and MP3 formats, and ar


FEBRUARY REVIEW, OR WHAT WENT ON IN OUR WORLD....
AEGiS News Service - March 3, 2004
Elizabeth Canepa
The month of February proved to be a time of great accomplishment and great challenge for us here at AEGiS. The worst occurred on the 21st, when water from a series of heavy rains, managed to get into the cable supplying our T1 connection to the Internet. It took MCI nearly six hours to get us back on-line. Later that


AT AEGiS, WE WANT YOU TO PUSH OUR BUTTONS!
AEGiS News Service - January 30, 2004
Elizabeth Canepa
AEGiS has partnered with Groundspring.org to bring you a new and improved way of showing your support for our effort in the fight against new HIV infections, and for people living with HIV/AIDS worldwide. New DonateNow buttons have been installed throughout the AEGiS website to remind our readers how important their su



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2004. AEGiS.